id	sid	tid	token	lemma	pos
dpc-4783	1	1	dermatology	dermatology	NOUN
dpc-4783	1	2	:	:	PUNCT
dpc-4783	1	3	practical	practical	ADJ
dpc-4783	1	4	and	and	CCONJ
dpc-4783	1	5	conceptual	conceptual	ADJ
dpc-4783	1	6	research	research	NOUN
dpc-4783	1	7	letter	letter	NOUN
dpc-4783	2	1	|	|	ADV
dpc-4783	2	2	dermatol	dermatol	ADJ
dpc-4783	2	3	pract	pract	NOUN
dpc-4783	2	4	concept	concept	NOUN
dpc-4783	2	5	.	.	PUNCT
dpc-4783	3	1	2024;14(4):e2024279	2024;14(4):e2024279	NUM
dpc-4783	3	2	1	1	NUM
dpc-4783	3	3	acrodermatitis	acrodermatitis	NOUN
dpc-4783	3	4	continua	continua	NOUN
dpc-4783	3	5	of	of	ADP
dpc-4783	3	6	hallopeau	hallopeau	PROPN
dpc-4783	3	7	successfully	successfully	ADV
dpc-4783	3	8	treated	treat	VERB
dpc-4783	3	9	with	with	ADP
dpc-4783	3	10	bimekizumab	bimekizumab	PROPN
dpc-4783	3	11	andrea	andrea	PROPN
dpc-4783	3	12	pagliara1,2	pagliara1,2	PROPN
dpc-4783	3	13	,	,	PUNCT
dpc-4783	3	14	federico	federico	PROPN
dpc-4783	3	15	bardazzi1	bardazzi1	PROPN
dpc-4783	3	16	,	,	PUNCT
dpc-4783	3	17	lidia	lidia	PROPN
dpc-4783	3	18	sacchelli1	sacchelli1	PROPN
dpc-4783	3	19	,	,	PUNCT
dpc-4783	3	20	federica	federica	PROPN
dpc-4783	3	21	filippi1,2	filippi1,2	PROPN
dpc-4783	3	22	,	,	PUNCT
dpc-4783	3	23	camilla	camilla	PROPN
dpc-4783	3	24	loi1	loi1	PROPN
dpc-4783	3	25	,	,	PUNCT
dpc-4783	3	26	bianca	bianca	PROPN
dpc-4783	3	27	maria	maria	PROPN
dpc-4783	3	28	piraccini1,2	piraccini1,2	PROPN
dpc-4783	3	29	,	,	PUNCT
dpc-4783	3	30	giacomo	giacomo	NOUN
dpc-4783	3	31	clarizio1,2	clarizio1,2	PROPN
dpc-4783	3	32	1	1	NUM
dpc-4783	3	33	irccs	irccs	NOUN
dpc-4783	3	34	azienda	azienda	PROPN
dpc-4783	3	35	ospedaliero	ospedaliero	PROPN
dpc-4783	3	36	-	-	PUNCT
dpc-4783	3	37	universitaria	universitaria	PROPN
dpc-4783	3	38	di	di	PROPN
dpc-4783	3	39	bologna	bologna	PROPN
dpc-4783	3	40	policlinico	policlinico	PROPN
dpc-4783	3	41	di	di	PROPN
dpc-4783	3	42	sant’orsola	sant’orsola	PROPN
dpc-4783	3	43	,	,	PUNCT
dpc-4783	3	44	dermatology	dermatology	NOUN
dpc-4783	3	45	unit	unit	NOUN
dpc-4783	3	46	2	2	NUM
dpc-4783	3	47	department	department	NOUN
dpc-4783	3	48	of	of	ADP
dpc-4783	3	49	medical	medical	ADJ
dpc-4783	3	50	and	and	CCONJ
dpc-4783	3	51	surgical	surgical	ADJ
dpc-4783	3	52	sciences	science	NOUN
dpc-4783	3	53	,	,	PUNCT
dpc-4783	3	54	alma	alma	NOUN
dpc-4783	3	55	mater	mater	NOUN
dpc-4783	3	56	studiorum	studiorum	PROPN
dpc-4783	3	57	,	,	PUNCT
dpc-4783	3	58	university	university	NOUN
dpc-4783	3	59	of	of	ADP
dpc-4783	3	60	bologna	bologna	NOUN
dpc-4783	3	61	,	,	PUNCT
dpc-4783	3	62	bologna	bologna	PROPN
dpc-4783	3	63	,	,	PUNCT
dpc-4783	3	64	italy	italy	PROPN
dpc-4783	3	65	key	key	ADJ
dpc-4783	3	66	words	word	NOUN
dpc-4783	3	67	:	:	PUNCT
dpc-4783	3	68	bimekizumab	bimekizumab	ADV
dpc-4783	3	69	,	,	PUNCT
dpc-4783	3	70	psoriasis	psoriasis	NOUN
dpc-4783	3	71	treatment	treatment	NOUN
dpc-4783	3	72	,	,	PUNCT
dpc-4783	3	73	biological	biological	ADJ
dpc-4783	3	74	therapy	therapy	NOUN
dpc-4783	3	75	,	,	PUNCT
dpc-4783	3	76	tnf	tnf	PROPN
dpc-4783	3	77	-	-	PUNCT
dpc-4783	3	78	α	α	PROPN
dpc-4783	3	79	,	,	PUNCT
dpc-4783	3	80	hallopeau	hallopeau	NOUN
dpc-4783	3	81	citation	citation	NOUN
dpc-4783	3	82	:	:	PUNCT
dpc-4783	3	83	pagliara	pagliara	NOUN
dpc-4783	3	84	a	a	DET
dpc-4783	3	85	,	,	PUNCT
dpc-4783	3	86	bardazzi	bardazzi	NOUN
dpc-4783	3	87	f	f	NOUN
dpc-4783	3	88	,	,	PUNCT
dpc-4783	3	89	sacchelli	sacchelli	PROPN
dpc-4783	3	90	l	l	PROPN
dpc-4783	3	91	,	,	PUNCT
dpc-4783	3	92	et	et	PROPN
dpc-4783	3	93	al	al	PROPN
dpc-4783	3	94	.	.	PROPN
dpc-4783	4	1	acrodermatitis	acrodermatitis	PROPN
dpc-4783	4	2	continua	continua	PROPN
dpc-4783	4	3	of	of	ADP
dpc-4783	4	4	hallopeau	hallopeau	PROPN
dpc-4783	4	5	successfully	successfully	ADV
dpc-4783	4	6	treated	treat	VERB
dpc-4783	4	7	with	with	ADP
dpc-4783	4	8	bimekizumab	bimekizumab	PROPN
dpc-4783	4	9	.	.	PUNCT
dpc-4783	5	1	dermatol	dermatol	NOUN
dpc-4783	5	2	 	 	SPACE
dpc-4783	5	3	pract	pract	PROPN
dpc-4783	5	4	concept	concept	NOUN
dpc-4783	5	5	.	.	PUNCT
dpc-4783	6	1	2024;14(4):e2024279	2024;14(4):e2024279	X
dpc-4783	6	2	.	.	PUNCT
dpc-4783	6	3	doi	doi	NOUN
dpc-4783	6	4	:	:	PUNCT
dpc-4783	6	5	https://doi.org/10.5826/dpc.1404a279	https://doi.org/10.5826/dpc.1404a279	NOUN
dpc-4783	6	6	accepted	accept	VERB
dpc-4783	6	7	:	:	PUNCT
dpc-4783	6	8	july	july	PROPN
dpc-4783	6	9	18	18	NUM
dpc-4783	6	10	,	,	PUNCT
dpc-4783	6	11	2024	2024	NUM
dpc-4783	6	12	;	;	PUNCT
dpc-4783	6	13	published	publish	VERB
dpc-4783	6	14	:	:	PUNCT
dpc-4783	7	1	october	october	PROPN
dpc-4783	7	2	2024	2024	NUM
dpc-4783	7	3	copyright	copyright	NOUN
dpc-4783	7	4	:	:	PUNCT
dpc-4783	7	5	©	©	PROPN
dpc-4783	7	6	2024	2024	NUM
dpc-4783	7	7	pagliara	pagliara	NOUN
dpc-4783	7	8	et	et	PROPN
dpc-4783	7	9	al	al	PROPN
dpc-4783	7	10	.	.	PUNCT
dpc-4783	8	1	this	this	PRON
dpc-4783	8	2	is	be	AUX
dpc-4783	8	3	an	an	DET
dpc-4783	8	4	open	open	ADJ
dpc-4783	8	5	-	-	PUNCT
dpc-4783	8	6	access	access	NOUN
dpc-4783	8	7	article	article	NOUN
dpc-4783	8	8	distributed	distribute	VERB
dpc-4783	8	9	under	under	ADP
dpc-4783	8	10	the	the	DET
dpc-4783	8	11	terms	term	NOUN
dpc-4783	8	12	of	of	ADP
dpc-4783	8	13	the	the	DET
dpc-4783	8	14	creative	creative	ADJ
dpc-4783	8	15	commons	common	NOUN
dpc-4783	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4783	8	17	license	license	NOUN
dpc-4783	8	18	(	(	PUNCT
dpc-4783	8	19	by	by	ADP
dpc-4783	8	20	-	-	PUNCT
dpc-4783	8	21	nc-4.0	nc-4.0	NOUN
dpc-4783	8	22	)	)	PUNCT
dpc-4783	8	23	,	,	PUNCT
dpc-4783	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4783	8	25	,	,	PUNCT
dpc-4783	8	26	which	which	PRON
dpc-4783	8	27	permits	permit	VERB
dpc-4783	8	28	unrestricted	unrestricted	ADJ
dpc-4783	8	29	noncommercial	noncommercial	ADJ
dpc-4783	8	30	use	use	NOUN
dpc-4783	8	31	,	,	PUNCT
dpc-4783	8	32	distribution	distribution	NOUN
dpc-4783	8	33	,	,	PUNCT
dpc-4783	8	34	and	and	CCONJ
dpc-4783	8	35	reproduction	reproduction	NOUN
dpc-4783	8	36	in	in	ADP
dpc-4783	8	37	any	any	DET
dpc-4783	8	38	medium	medium	NOUN
dpc-4783	8	39	,	,	PUNCT
dpc-4783	8	40	provided	provide	VERB
dpc-4783	8	41	the	the	DET
dpc-4783	8	42	original	original	ADJ
dpc-4783	8	43	authors	author	NOUN
dpc-4783	8	44	and	and	CCONJ
dpc-4783	8	45	source	source	NOUN
dpc-4783	8	46	are	be	AUX
dpc-4783	8	47	credited	credit	VERB
dpc-4783	8	48	.	.	PUNCT
dpc-4783	9	1	funding	funding	NOUN
dpc-4783	9	2	:	:	PUNCT
dpc-4783	9	3	none	none	NOUN
dpc-4783	9	4	.	.	PUNCT
dpc-4783	10	1	competing	compete	VERB
dpc-4783	10	2	interests	interest	NOUN
dpc-4783	10	3	:	:	PUNCT
dpc-4783	10	4	none	none	NOUN
dpc-4783	10	5	.	.	PUNCT
dpc-4783	11	1	authorship	authorship	NOUN
dpc-4783	11	2	:	:	PUNCT
dpc-4783	11	3	all	all	DET
dpc-4783	11	4	authors	author	NOUN
dpc-4783	11	5	have	have	AUX
dpc-4783	11	6	contributed	contribute	VERB
dpc-4783	11	7	significantly	significantly	ADV
dpc-4783	11	8	to	to	ADP
dpc-4783	11	9	this	this	DET
dpc-4783	11	10	publication	publication	NOUN
dpc-4783	11	11	.	.	PUNCT
dpc-4783	12	1	corresponding	correspond	VERB
dpc-4783	12	2	author	author	NOUN
dpc-4783	12	3	:	:	PUNCT
dpc-4783	12	4	andrea	andrea	PROPN
dpc-4783	12	5	pagliara	pagliara	PROPN
dpc-4783	12	6	,	,	PUNCT
dpc-4783	12	7	irccs	irccs	PROPN
dpc-4783	12	8	azienda	azienda	PROPN
dpc-4783	12	9	ospedaliero	ospedaliero	PROPN
dpc-4783	12	10	-	-	PUNCT
dpc-4783	12	11	universitaria	universitaria	PROPN
dpc-4783	12	12	di	di	PROPN
dpc-4783	12	13	bologna	bologna	PROPN
dpc-4783	12	14	policlinico	policlinico	PROPN
dpc-4783	12	15	di	di	PROPN
dpc-4783	12	16	sant’orsola	sant’orsola	PROPN
dpc-4783	12	17	,	,	PUNCT
dpc-4783	12	18	dermatology	dermatology	NOUN
dpc-4783	12	19	 	 	SPACE
dpc-4783	12	20	unit	unit	NOUN
dpc-4783	12	21	and	and	CCONJ
dpc-4783	12	22	department	department	PROPN
dpc-4783	12	23	of	of	ADP
dpc-4783	12	24	medical	medical	ADJ
dpc-4783	12	25	and	and	CCONJ
dpc-4783	12	26	surgical	surgical	ADJ
dpc-4783	12	27	sciences	science	NOUN
dpc-4783	12	28	,	,	PUNCT
dpc-4783	12	29	alma	alma	NOUN
dpc-4783	12	30	mater	mater	NOUN
dpc-4783	12	31	studiorum	studiorum	PROPN
dpc-4783	12	32	,	,	PUNCT
dpc-4783	12	33	university	university	NOUN
dpc-4783	12	34	of	of	ADP
dpc-4783	12	35	bologna	bologna	NOUN
dpc-4783	12	36	.	.	PUNCT
dpc-4783	13	1	e	e	X
dpc-4783	13	2	-	-	NOUN
dpc-4783	13	3	mail	mail	NOUN
dpc-4783	13	4	:	:	PUNCT
dpc-4783	13	5	andrea.pagliara7@studio.unibo.it	andrea.pagliara7@studio.unibo.it	PROPN
dpc-4783	13	6	introduction	introduction	NOUN
dpc-4783	13	7	acrodermatitis	acrodermatitis	NOUN
dpc-4783	13	8	continua	continua	PROPN
dpc-4783	13	9	of	of	ADP
dpc-4783	13	10	hallopeau	hallopeau	PROPN
dpc-4783	13	11	(	(	PUNCT
dpc-4783	13	12	ach	ach	PROPN
dpc-4783	13	13	)	)	PUNCT
dpc-4783	13	14	is	be	AUX
dpc-4783	13	15	a	a	DET
dpc-4783	13	16	rare	rare	ADJ
dpc-4783	13	17	form	form	NOUN
dpc-4783	13	18	of	of	ADP
dpc-4783	13	19	pustular	pustular	ADJ
dpc-4783	13	20	psoriasis	psoriasis	NOUN
dpc-4783	13	21	characterized	characterize	VERB
dpc-4783	13	22	by	by	ADP
dpc-4783	13	23	recurrent	recurrent	ADJ
dpc-4783	13	24	eruptions	eruption	NOUN
dpc-4783	13	25	of	of	ADP
dpc-4783	13	26	sterile	sterile	ADJ
dpc-4783	13	27	pustules	pustule	NOUN
dpc-4783	13	28	localized	localize	VERB
dpc-4783	13	29	on	on	ADP
dpc-4783	13	30	the	the	DET
dpc-4783	13	31	distal	distal	ADJ
dpc-4783	13	32	phalanges	phalanx	NOUN
dpc-4783	13	33	of	of	ADP
dpc-4783	13	34	hands	hand	NOUN
dpc-4783	13	35	and	and	CCONJ
dpc-4783	13	36	feet	foot	NOUN
dpc-4783	13	37	that	that	PRON
dpc-4783	13	38	can	can	AUX
dpc-4783	13	39	induce	induce	VERB
dpc-4783	13	40	onychodystrophy	onychodystrophy	NOUN
dpc-4783	13	41	and	and	CCONJ
dpc-4783	13	42	anonychia	anonychia	VERB
dpc-4783	13	43	as	as	ADV
dpc-4783	13	44	well	well	ADV
dpc-4783	13	45	as	as	ADP
dpc-4783	13	46	osteolysis	osteolysis	NOUN
dpc-4783	13	47	of	of	ADP
dpc-4783	13	48	the	the	DET
dpc-4783	13	49	affected	affected	ADJ
dpc-4783	13	50	phalanges	phalanx	NOUN
dpc-4783	13	51	[	[	X
dpc-4783	13	52	1	1	NUM
dpc-4783	13	53	]	]	PUNCT
dpc-4783	13	54	.	.	PUNCT
dpc-4783	14	1	case	case	NOUN
dpc-4783	14	2	presentations	presentation	VERB
dpc-4783	14	3	a	a	DET
dpc-4783	14	4	74	74	NUM
dpc-4783	14	5	-	-	PUNCT
dpc-4783	14	6	year	year	NOUN
dpc-4783	14	7	-	-	PUNCT
dpc-4783	14	8	old	old	ADJ
dpc-4783	14	9	caucasian	caucasian	ADJ
dpc-4783	14	10	man	man	NOUN
dpc-4783	14	11	came	come	VERB
dpc-4783	14	12	to	to	ADP
dpc-4783	14	13	consultation	consultation	NOUN
dpc-4783	14	14	presenting	present	VERB
dpc-4783	14	15	pustular	pustular	ADJ
dpc-4783	14	16	lesions	lesion	NOUN
dpc-4783	14	17	involving	involve	VERB
dpc-4783	14	18	all	all	DET
dpc-4783	14	19	the	the	DET
dpc-4783	14	20	fingers	finger	NOUN
dpc-4783	14	21	of	of	ADP
dpc-4783	14	22	the	the	DET
dpc-4783	14	23	hands	hand	NOUN
dpc-4783	14	24	and	and	CCONJ
dpc-4783	14	25	the	the	DET
dpc-4783	14	26	toes	toe	NOUN
dpc-4783	14	27	.	.	PUNCT
dpc-4783	15	1	on	on	ADP
dpc-4783	15	2	clinical	clinical	ADJ
dpc-4783	15	3	observation	observation	NOUN
dpc-4783	15	4	,	,	PUNCT
dpc-4783	15	5	onychodystrophy	onychodystrophy	NOUN
dpc-4783	15	6	of	of	ADP
dpc-4783	15	7	some	some	DET
dpc-4783	15	8	nails	nail	NOUN
dpc-4783	15	9	of	of	ADP
dpc-4783	15	10	the	the	DET
dpc-4783	15	11	hands	hand	NOUN
dpc-4783	15	12	along	along	ADP
dpc-4783	15	13	with	with	ADP
dpc-4783	15	14	pustules	pustule	NOUN
dpc-4783	15	15	and	and	CCONJ
dpc-4783	15	16	edema	edema	NOUN
dpc-4783	15	17	were	be	AUX
dpc-4783	15	18	present	present	ADJ
dpc-4783	15	19	(	(	PUNCT
dpc-4783	15	20	figure	figure	NOUN
dpc-4783	15	21	1	1	NUM
dpc-4783	15	22	)	)	PUNCT
dpc-4783	15	23	.	.	PUNCT
dpc-4783	16	1	the	the	DET
dpc-4783	16	2	patient	patient	NOUN
dpc-4783	16	3	also	also	ADV
dpc-4783	16	4	complained	complain	VERB
dpc-4783	16	5	of	of	ADP
dpc-4783	16	6	joint	joint	ADJ
dpc-4783	16	7	mobility	mobility	NOUN
dpc-4783	16	8	limitation	limitation	NOUN
dpc-4783	16	9	and	and	CCONJ
dpc-4783	16	10	pain	pain	NOUN
dpc-4783	16	11	.	.	PUNCT
dpc-4783	17	1	the	the	DET
dpc-4783	17	2	patient	patient	NOUN
dpc-4783	17	3	was	be	AUX
dpc-4783	17	4	already	already	ADV
dpc-4783	17	5	being	be	AUX
dpc-4783	17	6	followed	follow	VERB
dpc-4783	17	7	in	in	ADP
dpc-4783	17	8	our	our	PRON
dpc-4783	17	9	department	department	NOUN
dpc-4783	17	10	for	for	ADP
dpc-4783	17	11	a	a	DET
dpc-4783	17	12	mild	mild	ADJ
dpc-4783	17	13	form	form	NOUN
dpc-4783	17	14	of	of	ADP
dpc-4783	17	15	plaque	plaque	NOUN
dpc-4783	17	16	psoriasis	psoriasis	NOUN
dpc-4783	17	17	involving	involve	VERB
dpc-4783	17	18	the	the	DET
dpc-4783	17	19	trunk	trunk	NOUN
dpc-4783	17	20	and	and	CCONJ
dpc-4783	17	21	the	the	DET
dpc-4783	17	22	limbs	limb	NOUN
dpc-4783	17	23	,	,	PUNCT
dpc-4783	17	24	with	with	ADP
dpc-4783	17	25	an	an	DET
dpc-4783	17	26	on	on	ADP
dpc-4783	17	27	-	-	PUNCT
dpc-4783	17	28	demand	demand	NOUN
dpc-4783	17	29	topical	topical	ADJ
dpc-4783	17	30	therapy	therapy	NOUN
dpc-4783	17	31	.	.	PUNCT
dpc-4783	18	1	during	during	ADP
dpc-4783	18	2	the	the	DET
dpc-4783	18	3	last	last	ADJ
dpc-4783	18	4	3	3	NUM
dpc-4783	18	5	years	year	NOUN
dpc-4783	18	6	lesions	lesion	NOUN
dpc-4783	18	7	were	be	AUX
dpc-4783	18	8	spread	spread	VERB
dpc-4783	18	9	on	on	ADP
dpc-4783	18	10	the	the	DET
dpc-4783	18	11	hand	hand	NOUN
dpc-4783	18	12	,	,	PUNCT
dpc-4783	18	13	but	but	CCONJ
dpc-4783	18	14	the	the	DET
dpc-4783	18	15	trunk	trunk	NOUN
dpc-4783	18	16	was	be	AUX
dpc-4783	18	17	spared	spare	VERB
dpc-4783	18	18	.	.	PUNCT
dpc-4783	19	1	the	the	DET
dpc-4783	19	2	patient	patient	NOUN
dpc-4783	19	3	was	be	AUX
dpc-4783	19	4	first	first	ADV
dpc-4783	19	5	treated	treat	VERB
dpc-4783	19	6	with	with	ADP
dpc-4783	19	7	adalimumab	adalimumab	NOUN
dpc-4783	19	8	40	40	NUM
dpc-4783	19	9	mg	mg	NOUN
dpc-4783	19	10	every	every	DET
dpc-4783	19	11	other	other	ADJ
dpc-4783	19	12	week	week	NOUN
dpc-4783	19	13	for	for	ADP
dpc-4783	19	14	6	6	NUM
dpc-4783	19	15	months	month	NOUN
dpc-4783	19	16	,	,	PUNCT
dpc-4783	19	17	with	with	ADP
dpc-4783	19	18	unsatisfactory	unsatisfactory	ADJ
dpc-4783	19	19	results	result	NOUN
dpc-4783	19	20	.	.	PUNCT
dpc-4783	20	1	one	one	NUM
dpc-4783	20	2	year	year	NOUN
dpc-4783	20	3	later	later	ADV
dpc-4783	20	4	,	,	PUNCT
dpc-4783	20	5	he	he	PRON
dpc-4783	20	6	came	come	VERB
dpc-4783	20	7	back	back	ADV
dpc-4783	20	8	to	to	ADP
dpc-4783	20	9	consultation	consultation	NOUN
dpc-4783	20	10	with	with	ADP
dpc-4783	20	11	an	an	DET
dpc-4783	20	12	evident	evident	ADJ
dpc-4783	20	13	form	form	NOUN
dpc-4783	20	14	of	of	ADP
dpc-4783	20	15	ach	ach	PROPN
dpc-4783	20	16	involving	involve	VERB
dpc-4783	20	17	the	the	DET
dpc-4783	20	18	10	10	NUM
dpc-4783	20	19	fingers	finger	NOUN
dpc-4783	20	20	and	and	CCONJ
dpc-4783	20	21	feet	foot	NOUN
dpc-4783	20	22	.	.	PUNCT
dpc-4783	21	1	thus	thus	ADV
dpc-4783	21	2	,	,	PUNCT
dpc-4783	21	3	we	we	PRON
dpc-4783	21	4	decided	decide	VERB
dpc-4783	21	5	to	to	PART
dpc-4783	21	6	start	start	VERB
dpc-4783	21	7	a	a	DET
dpc-4783	21	8	therapeutic	therapeutic	ADJ
dpc-4783	21	9	protocol	protocol	NOUN
dpc-4783	21	10	with	with	ADP
dpc-4783	21	11	bimekizumab	bimekizumab	NOUN
dpc-4783	21	12	320	320	NUM
dpc-4783	21	13	mg	mg	NOUN
dpc-4783	21	14	administered	administer	VERB
dpc-4783	21	15	subcutaneously	subcutaneously	ADV
dpc-4783	21	16	every	every	DET
dpc-4783	21	17	4	4	NUM
dpc-4783	21	18	weeks	week	NOUN
dpc-4783	21	19	.	.	PUNCT
dpc-4783	22	1	after	after	ADP
dpc-4783	22	2	the	the	DET
dpc-4783	22	3	first	first	ADJ
dpc-4783	22	4	administration	administration	NOUN
dpc-4783	22	5	,	,	PUNCT
dpc-4783	22	6	the	the	DET
dpc-4783	22	7	clinical	clinical	ADJ
dpc-4783	22	8	aspect	aspect	NOUN
dpc-4783	22	9	had	have	AUX
dpc-4783	22	10	improved	improve	VERB
dpc-4783	22	11	considerably	considerably	ADV
dpc-4783	22	12	:	:	PUNCT
dpc-4783	22	13	the	the	DET
dpc-4783	22	14	erythema	erythema	NOUN
dpc-4783	22	15	and	and	CCONJ
dpc-4783	22	16	the	the	DET
dpc-4783	22	17	pustules	pustule	NOUN
dpc-4783	22	18	had	have	AUX
dpc-4783	22	19	almost	almost	ADV
dpc-4783	22	20	completely	completely	ADV
dpc-4783	22	21	disappeared	disappear	VERB
dpc-4783	22	22	,	,	PUNCT
dpc-4783	22	23	the	the	DET
dpc-4783	22	24	edema	edema	NOUN
dpc-4783	22	25	retrieved	retrieve	VERB
dpc-4783	22	26	,	,	PUNCT
dpc-4783	22	27	and	and	CCONJ
dpc-4783	22	28	the	the	DET
dpc-4783	22	29	patient	patient	NOUN
dpc-4783	22	30	regained	regain	VERB
dpc-4783	22	31	the	the	DET
dpc-4783	22	32	mobility	mobility	NOUN
dpc-4783	22	33	of	of	ADP
dpc-4783	22	34	flexion	flexion	NOUN
dpc-4783	22	35	extension	extension	NOUN
dpc-4783	22	36	of	of	ADP
dpc-4783	22	37	the	the	DET
dpc-4783	22	38	fingers	finger	NOUN
dpc-4783	22	39	(	(	PUNCT
dpc-4783	22	40	figure	figure	NOUN
dpc-4783	22	41	2	2	NUM
dpc-4783	22	42	)	)	PUNCT
dpc-4783	22	43	.	.	PUNCT
dpc-4783	23	1	his	his	PRON
dpc-4783	23	2	quality	quality	NOUN
dpc-4783	23	3	of	of	ADP
dpc-4783	23	4	life	life	NOUN
dpc-4783	23	5	has	have	AUX
dpc-4783	23	6	significantly	significantly	ADV
dpc-4783	23	7	improved	improve	VERB
dpc-4783	23	8	,	,	PUNCT
dpc-4783	23	9	as	as	SCONJ
dpc-4783	23	10	the	the	DET
dpc-4783	23	11	social	social	ADJ
dpc-4783	23	12	impact	impact	NOUN
dpc-4783	23	13	of	of	ADP
dpc-4783	23	14	the	the	DET
dpc-4783	23	15	uncontrolled	uncontrolled	ADJ
dpc-4783	23	16	pathology	pathology	NOUN
dpc-4783	23	17	was	be	AUX
dpc-4783	23	18	extremely	extremely	ADV
dpc-4783	23	19	disabling	disabling	ADJ
dpc-4783	23	20	.	.	PUNCT
dpc-4783	24	1	subsequently	subsequently	ADV
dpc-4783	24	2	,	,	PUNCT
dpc-4783	24	3	a	a	DET
dpc-4783	24	4	47	47	NUM
dpc-4783	24	5	-	-	PUNCT
dpc-4783	24	6	year	year	NOUN
dpc-4783	24	7	-	-	PUNCT
dpc-4783	24	8	old	old	ADJ
dpc-4783	24	9	caucasian	caucasian	ADJ
dpc-4783	24	10	female	female	ADJ
dpc-4783	24	11	patient	patient	NOUN
dpc-4783	24	12	,	,	PUNCT
dpc-4783	24	13	also	also	ADV
dpc-4783	24	14	diagnosed	diagnose	VERB
dpc-4783	24	15	with	with	ADP
dpc-4783	24	16	ach	ach	PROPN
dpc-4783	24	17	,	,	PUNCT
dpc-4783	24	18	was	be	AUX
dpc-4783	24	19	treated	treat	VERB
dpc-4783	24	20	with	with	ADP
dpc-4783	24	21	suspended	suspend	VERB
dpc-4783	24	22	brodalumab	brodalumab	NOUN
dpc-4783	24	23	(	(	PUNCT
dpc-4783	24	24	initially	initially	ADV
dpc-4783	24	25	treated	treat	VERB
dpc-4783	24	26	with	with	ADP
dpc-4783	24	27	adalimumab	adalimumab	NOUN
dpc-4783	24	28	and	and	CCONJ
dpc-4783	24	29	secukinumab	secukinumab	NOUN
dpc-4783	24	30	)	)	PUNCT
dpc-4783	24	31	and	and	CCONJ
dpc-4783	24	32	was	be	AUX
dpc-4783	24	33	started	start	VERB
dpc-4783	24	34	on	on	ADP
dpc-4783	24	35	the	the	DET
dpc-4783	24	36	same	same	ADJ
dpc-4783	24	37	regimen	regiman	NOUN
dpc-4783	24	38	(	(	PUNCT
dpc-4783	24	39	bimekizumab	bimekizumab	NOUN
dpc-4783	24	40	320	320	NUM
dpc-4783	24	41	mg	mg	NOUN
dpc-4783	24	42	)	)	PUNCT
dpc-4783	24	43	.	.	PUNCT
dpc-4783	25	1	a	a	DET
dpc-4783	25	2	subtotal	subtotal	ADJ
dpc-4783	25	3	remission	remission	NOUN
dpc-4783	25	4	was	be	AUX
dpc-4783	25	5	obtained	obtain	VERB
dpc-4783	25	6	after	after	ADP
dpc-4783	25	7	the	the	DET
dpc-4783	25	8	second	second	ADJ
dpc-4783	25	9	administration	administration	NOUN
dpc-4783	25	10	and	and	CCONJ
dpc-4783	25	11	is	be	AUX
dpc-4783	25	12	still	still	ADV
dpc-4783	25	13	maintained	maintain	VERB
dpc-4783	25	14	to	to	ADP
dpc-4783	25	15	date	date	NOUN
dpc-4783	25	16	.	.	PUNCT
dpc-4783	26	1	2	2	NUM
dpc-4783	26	2	research	research	NOUN
dpc-4783	26	3	letter	letter	NOUN
dpc-4783	26	4	|	|	ADV
dpc-4783	26	5	dermatol	dermatol	ADJ
dpc-4783	26	6	pract	pract	NOUN
dpc-4783	26	7	concept	concept	NOUN
dpc-4783	26	8	.	.	PUNCT
dpc-4783	27	1	2024;14(4):e2024279	2024;14(4):e2024279	NUM
dpc-4783	27	2	finally	finally	ADV
dpc-4783	27	3	,	,	PUNCT
dpc-4783	27	4	an	an	DET
dpc-4783	27	5	86	86	NUM
dpc-4783	27	6	-	-	PUNCT
dpc-4783	27	7	year	year	NOUN
dpc-4783	27	8	-	-	PUNCT
dpc-4783	27	9	old	old	ADJ
dpc-4783	27	10	caucasian	caucasian	ADJ
dpc-4783	27	11	female	female	ADJ
dpc-4783	27	12	patient	patient	NOUN
dpc-4783	27	13	with	with	ADP
dpc-4783	27	14	a	a	DET
dpc-4783	27	15	diagnosis	diagnosis	NOUN
dpc-4783	27	16	of	of	ADP
dpc-4783	27	17	ach	ach	PROPN
dpc-4783	27	18	involving	involve	VERB
dpc-4783	27	19	some	some	DET
dpc-4783	27	20	fingers	finger	NOUN
dpc-4783	27	21	had	have	AUX
dpc-4783	27	22	obtained	obtain	VERB
dpc-4783	27	23	no	no	DET
dpc-4783	27	24	response	response	NOUN
dpc-4783	27	25	with	with	ADP
dpc-4783	27	26	adalimumab	adalimumab	NOUN
dpc-4783	27	27	after	after	ADP
dpc-4783	27	28	6	6	NUM
dpc-4783	27	29	months	month	NOUN
dpc-4783	27	30	and	and	CCONJ
dpc-4783	27	31	was	be	AUX
dpc-4783	27	32	started	start	VERB
dpc-4783	27	33	on	on	ADP
dpc-4783	27	34	bimekizumab	bimekizumab	NOUN
dpc-4783	27	35	as	as	ADV
dpc-4783	27	36	aforementioned	aforementione	VERB
dpc-4783	27	37	.	.	PUNCT
dpc-4783	28	1	clinical	clinical	ADJ
dpc-4783	28	2	response	response	NOUN
dpc-4783	28	3	was	be	AUX
dpc-4783	28	4	good	good	ADJ
dpc-4783	28	5	after	after	ADP
dpc-4783	28	6	the	the	DET
dpc-4783	28	7	second	second	ADJ
dpc-4783	28	8	administration	administration	NOUN
dpc-4783	28	9	.	.	PUNCT
dpc-4783	29	1	conclusions	conclusion	NOUN
dpc-4783	29	2	these	these	DET
dpc-4783	29	3	cases	case	NOUN
dpc-4783	29	4	contribute	contribute	VERB
dpc-4783	29	5	to	to	ADP
dpc-4783	29	6	expanding	expand	VERB
dpc-4783	29	7	current	current	ADJ
dpc-4783	29	8	knowledge	knowledge	NOUN
dpc-4783	29	9	about	about	ADP
dpc-4783	29	10	this	this	DET
dpc-4783	29	11	pathology	pathology	NOUN
dpc-4783	29	12	that	that	PRON
dpc-4783	29	13	is	be	AUX
dpc-4783	29	14	not	not	PART
dpc-4783	29	15	seen	see	VERB
dpc-4783	29	16	frequently	frequently	ADV
dpc-4783	29	17	and	and	CCONJ
dpc-4783	29	18	of	of	ADP
dpc-4783	29	19	which	which	DET
dpc-4783	29	20	management	management	NOUN
dpc-4783	29	21	is	be	AUX
dpc-4783	29	22	still	still	ADV
dpc-4783	29	23	not	not	PART
dpc-4783	29	24	standardized	standardize	VERB
dpc-4783	29	25	.	.	PUNCT
dpc-4783	30	1	the	the	DET
dpc-4783	30	2	excellent	excellent	ADJ
dpc-4783	30	3	clinical	clinical	ADJ
dpc-4783	30	4	response	response	NOUN
dpc-4783	30	5	of	of	ADP
dpc-4783	30	6	the	the	DET
dpc-4783	30	7	patients	patient	NOUN
dpc-4783	30	8	to	to	ADP
dpc-4783	30	9	the	the	DET
dpc-4783	30	10	therapy	therapy	NOUN
dpc-4783	30	11	provides	provide	VERB
dpc-4783	30	12	further	further	ADJ
dpc-4783	30	13	information	information	NOUN
dpc-4783	30	14	regarding	regard	VERB
dpc-4783	30	15	not	not	PART
dpc-4783	30	16	only	only	ADV
dpc-4783	30	17	the	the	DET
dpc-4783	30	18	pathogenetic	pathogenetic	ADJ
dpc-4783	30	19	mechanisms	mechanism	NOUN
dpc-4783	30	20	underlying	underlie	VERB
dpc-4783	30	21	ach	ach	PROPN
dpc-4783	30	22	but	but	CCONJ
dpc-4783	30	23	also	also	ADV
dpc-4783	30	24	the	the	DET
dpc-4783	30	25	medical	medical	ADJ
dpc-4783	30	26	management	management	NOUN
dpc-4783	30	27	.	.	PUNCT
dpc-4783	31	1	there	there	PRON
dpc-4783	31	2	are	be	VERB
dpc-4783	31	3	no	no	DET
dpc-4783	31	4	randomized	randomized	ADJ
dpc-4783	31	5	clinical	clinical	ADJ
dpc-4783	31	6	trials	trial	NOUN
dpc-4783	31	7	or	or	CCONJ
dpc-4783	31	8	case	case	NOUN
dpc-4783	31	9	series	series	NOUN
dpc-4783	31	10	regarding	regard	VERB
dpc-4783	31	11	the	the	DET
dpc-4783	31	12	use	use	NOUN
dpc-4783	31	13	of	of	ADP
dpc-4783	31	14	bimekizumab	bimekizumab	NOUN
dpc-4783	31	15	in	in	ADP
dpc-4783	31	16	ach	ach	PROPN
dpc-4783	31	17	.	.	PUNCT
dpc-4783	32	1	in	in	ADP
dpc-4783	32	2	scientific	scientific	ADJ
dpc-4783	32	3	literature	literature	NOUN
dpc-4783	32	4	,	,	PUNCT
dpc-4783	32	5	there	there	PRON
dpc-4783	32	6	exists	exist	VERB
dpc-4783	32	7	a	a	DET
dpc-4783	32	8	documented	document	VERB
dpc-4783	32	9	case	case	NOUN
dpc-4783	32	10	regarding	regard	VERB
dpc-4783	32	11	bimekizumab	bimekizumab	NOUN
dpc-4783	32	12	in	in	ADP
dpc-4783	32	13	ach	ach	PROPN
dpc-4783	32	14	in	in	ADP
dpc-4783	32	15	which	which	DET
dpc-4783	32	16	improvement	improvement	NOUN
dpc-4783	32	17	was	be	AUX
dpc-4783	32	18	gained	gain	VERB
dpc-4783	32	19	in	in	ADP
dpc-4783	32	20	2	2	NUM
dpc-4783	32	21	months	month	NOUN
dpc-4783	32	22	[	[	X
dpc-4783	32	23	2	2	NUM
dpc-4783	32	24	]	]	PUNCT
dpc-4783	32	25	.	.	PUNCT
dpc-4783	33	1	in	in	ADP
dpc-4783	33	2	our	our	PRON
dpc-4783	33	3	experience	experience	NOUN
dpc-4783	33	4	,	,	PUNCT
dpc-4783	33	5	after	after	ADP
dpc-4783	33	6	6	6	NUM
dpc-4783	33	7	months	month	NOUN
dpc-4783	33	8	of	of	ADP
dpc-4783	33	9	treatment	treatment	NOUN
dpc-4783	33	10	,	,	PUNCT
dpc-4783	33	11	this	this	DET
dpc-4783	33	12	molecule	molecule	NOUN
dpc-4783	33	13	has	have	AUX
dpc-4783	33	14	proved	prove	VERB
dpc-4783	33	15	to	to	PART
dpc-4783	33	16	be	be	AUX
dpc-4783	33	17	safe	safe	ADJ
dpc-4783	33	18	,	,	PUNCT
dpc-4783	33	19	effective	effective	ADJ
dpc-4783	33	20	,	,	PUNCT
dpc-4783	33	21	but	but	CCONJ
dpc-4783	33	22	above	above	ADP
dpc-4783	33	23	all	all	PRON
dpc-4783	33	24	,	,	PUNCT
dpc-4783	33	25	quick	quick	ADJ
dpc-4783	33	26	to	to	PART
dpc-4783	33	27	act	act	VERB
dpc-4783	33	28	compared	compare	VERB
dpc-4783	33	29	to	to	ADP
dpc-4783	33	30	other	other	ADJ
dpc-4783	33	31	treatments	treatment	NOUN
dpc-4783	33	32	.	.	PUNCT
dpc-4783	34	1	references	reference	NOUN
dpc-4783	34	2	1	1	NUM
dpc-4783	34	3	.	.	PUNCT
dpc-4783	34	4	ranugha	ranugha	PROPN
dpc-4783	34	5	ps	ps	PROPN
dpc-4783	34	6	,	,	PUNCT
dpc-4783	34	7	kumari	kumari	PROPN
dpc-4783	34	8	r	r	PROPN
dpc-4783	34	9	,	,	PUNCT
dpc-4783	34	10	thappa	thappa	PROPN
dpc-4783	34	11	dm	dm	PROPN
dpc-4783	34	12	.	.	PUNCT
dpc-4783	34	13	acrodermatitis	acrodermatitis	PROPN
dpc-4783	34	14	continua	continua	PROPN
dpc-4783	34	15	of	of	ADP
dpc-4783	34	16	hallopeau	hallopeau	PROPN
dpc-4783	34	17	evolving	evolve	VERB
dpc-4783	34	18	into	into	ADP
dpc-4783	34	19	generalised	generalise	VERB
dpc-4783	34	20	pustular	pustular	ADJ
dpc-4783	34	21	psoriasis	psoriasis	NOUN
dpc-4783	34	22	.	.	PUNCT
dpc-4783	34	23	 	 	SPACE
dpc-4783	35	1	indian	indian	PROPN
dpc-4783	35	2	j	j	PROPN
dpc-4783	35	3	dermatol	dermatol	NOUN
dpc-4783	35	4	.	.	PUNCT
dpc-4783	36	1	2013;58(2):161	2013;58(2):161	NUM
dpc-4783	36	2	.	.	PUNCT
dpc-4783	37	1	doi:10.4103/0019	doi:10.4103/0019	PROPN
dpc-4783	37	2	-	-	PUNCT
dpc-4783	37	3	5154.108096	5154.108096	NUM
dpc-4783	37	4	.	.	PUNCT
dpc-4783	38	1	2	2	NUM
dpc-4783	38	2	.	.	X
dpc-4783	38	3	cirone	cirone	PROPN
dpc-4783	38	4	kd	kd	PROPN
dpc-4783	38	5	,	,	PUNCT
dpc-4783	38	6	lovegrove	lovegrove	PROPN
dpc-4783	38	7	fe	fe	PROPN
dpc-4783	38	8	.	.	PROPN
dpc-4783	38	9	acrodermatitis	acrodermatitis	PROPN
dpc-4783	38	10	continua	continua	PROPN
dpc-4783	38	11	of	of	ADP
dpc-4783	38	12	hallopeau	hallopeau	PROPN
dpc-4783	38	13	successfully	successfully	ADV
dpc-4783	38	14	treated	treat	VERB
dpc-4783	38	15	with	with	ADP
dpc-4783	38	16	bimekizumab	bimekizumab	NOUN
dpc-4783	38	17	:	:	PUNCT
dpc-4783	38	18	a	a	DET
dpc-4783	38	19	case	case	NOUN
dpc-4783	38	20	report	report	NOUN
dpc-4783	38	21	.	.	PUNCT
dpc-4783	38	22	  	  	SPACE
dpc-4783	39	1	sage	sage	VERB
dpc-4783	39	2	open	open	ADJ
dpc-4783	39	3	med	med	ADJ
dpc-4783	39	4	case	case	NOUN
dpc-4783	39	5	rep	rep	PROPN
dpc-4783	39	6	.	.	PROPN
dpc-4783	39	7	2023	2023	NUM
dpc-4783	39	8	;	;	PUNCT
dpc-4783	39	9	11:2050313x231160937	11:2050313x231160937	X
dpc-4783	39	10	.	.	PUNCT
dpc-4783	40	1	published	publish	VERB
dpc-4783	40	2	2023	2023	NUM
dpc-4783	40	3	mar	mar	PROPN
dpc-4783	40	4	21	21	NUM
dpc-4783	40	5	.	.	PUNCT
dpc-4783	41	1	doi:10.1177/2050313x231160937	doi:10.1177/2050313x231160937	PROPN
dpc-4783	41	2	.	.	PUNCT
dpc-4783	42	1	figure	figure	NOUN
dpc-4783	42	2	1	1	NUM
dpc-4783	42	3	.	.	PUNCT
dpc-4783	43	1	pustules	pustule	NOUN
dpc-4783	43	2	and	and	CCONJ
dpc-4783	43	3	onychodystrophy	onychodystrophy	NOUN
dpc-4783	43	4	affecting	affect	VERB
dpc-4783	43	5	all	all	DET
dpc-4783	43	6	the	the	DET
dpc-4783	43	7	distal	distal	ADJ
dpc-4783	43	8	fingers	finger	NOUN
dpc-4783	43	9	and	and	CCONJ
dpc-4783	43	10	nails	nail	NOUN
dpc-4783	43	11	of	of	ADP
dpc-4783	43	12	the	the	DET
dpc-4783	43	13	hands	hand	NOUN
dpc-4783	43	14	.	.	PUNCT
dpc-4783	44	1	figure	figure	NOUN
dpc-4783	44	2	2	2	NUM
dpc-4783	44	3	.	.	PUNCT
dpc-4783	44	4	almost	almost	ADV
dpc-4783	44	5	complete	complete	ADJ
dpc-4783	44	6	improvement	improvement	NOUN
dpc-4783	44	7	after	after	ADP
dpc-4783	44	8	only	only	ADV
dpc-4783	44	9	1	1	NUM
dpc-4783	44	10	administration	administration	NOUN
dpc-4783	44	11	of	of	ADP
dpc-4783	44	12	bimekizumab	bimekizumab	PROPN
dpc-4783	44	13	,	,	PUNCT
dpc-4783	44	14	a	a	DET
dpc-4783	44	15	month	month	NOUN
dpc-4783	44	16	after	after	ADP
dpc-4783	44	17	the	the	DET
dpc-4783	44	18	start	start	NOUN
dpc-4783	44	19	of	of	ADP
dpc-4783	44	20	the	the	DET
dpc-4783	44	21	therapy	therapy	NOUN
dpc-4783	44	22	.	.	PUNCT